Charles Schwab (SCHW) has been on investors’ minds this month, with shares slipping about 4% over the past month and down 7% ...
BofA analyst Michael Ryskin lowered the firm’s price target on Charles River (CRL) to $210 from $220 and keeps a Neutral rating on the shares. The Life Sciences Tools sector underperformed again in ...
Morgan Stanley lowered the firm’s price target on Charles River (CRL) to $220 from $225 and keeps an Equal Weight rating on the shares. The firm is adjusting its model to reflect “seasonality and ...